Tokyo, Oct. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059356) titled 'Nationwide Survey of Unilateral Vocal Fold Paralysis' on Oct. 9.
Study Type:
Observational
Primary Sponsor:
Institute - International University of Health and Welfare
Condition:
Condition - Unilateral vocal fold paralysis, Recurrent nerve palsy, Laryngeal paralysis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We will conduct a nationwide survey of patients with unilateral vocal cord paralysis, including age of onset, longest vocal duration, severity of hoarseness using the Voice Handicap Index (
, etc.), causative disease, duration of illness, and treatment experience.
Based on these results,
Estimate the number of patients with unilateral vocal fold paralysis in Japan
(2) Database development to create future diagnostic criteria and severity classifications for unilateral vocal fold paralysis,
3. to compare the outcomes of treatment methods for unilateral vocal fold paralysis, such as voice therapy, intravocal fold injection, and surgical treatment.
Translated with DeepL.com (free version)
Basic objectives2 - Others
Eligibility:
Age-lower limit - 1
years-old
=
Gender - Male and Female
Key inclusion criteria - Unilateral vocal fold paralysis diagnosed as
recurrent nerve palsy (ICD-10 code G52.2),
laryngeal or vocal fold paralysis (ICD-10 code J38.0)
between January 1, 2023 and December 31, 2024
Key exclusion criteria - If the registrant is deemed unsuitable
Target Size - 2000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 09 Month 10 Day
Anticipated trial start date - 2025 Year 11 Month 15 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066468
Disclaimer: Curated by HT Syndication.
